GEORGES GEMAYEL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEORGES GEMAYEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEORGES GEMAYEL. GEORGES GEMAYEL is Executive Vice President in GENZYME CORP ($GENZ) and Director in NPS PHARMACEUTICALS INC ($NPSP) and Director in Raptor Pharmaceutical Corp ($RPTP) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and Director in Dimension Therapeutics, Inc. ($DMTX) and Director in Gemini Therapeutics, Inc. /DE ($FSDC).
Latest Insider Trading Transactions of GEORGES GEMAYEL
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DMTX, FSDC, GENZ, RPTP, MNTA, NPSP, SUPN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | FSDC | Gemini Therapeutic ... | GEMAYEL GEORGES | Director | Option Exercise | A | 11.92 | 45,466 | 541,955 | 45,466 | |
Aug 07 2020 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | M | 14.84 | 10,000 | 148,400 | 10,000 | |
Aug 07 2020 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Sell | S | 33.00 | 10,000 | 330,000 | 14,090 | 24.1 K to 14.1 K (-41.51 %) |
Aug 07 2020 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Buy | M | 14.84 | 10,000 | 148,400 | 24,090 | 14.1 K to 24.1 K (+70.97 %) |
Jul 30 2020 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | M | 14.84 | 10,000 | 148,400 | 20,000 | |
Jul 30 2020 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Sell | S | 30.00 | 10,000 | 300,000 | 14,090 | 24.1 K to 14.1 K (-41.51 %) |
Jul 30 2020 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Buy | M | 14.84 | 10,000 | 148,400 | 24,090 | 14.1 K to 24.1 K (+70.97 %) |
Jun 24 2020 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | A | 38.09 | 25,000 | 952,250 | 25,000 | |
Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | M | 0.00 | 4,356 | 0 | 0 | |
Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | A | 12.64 | 25,000 | 316,000 | 25,000 | |
Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Buy | M | 0.00 | 4,356 | 0 | 14,090 | 9.7 K to 14.1 K (+44.75 %) |
Feb 26 2019 | SUPN | SUPERNUS PHARMACEU ... | GEMAYEL GEORGES | Director | Option Exercise | A | 36.75 | 12,427 | 456,692 | 12,427 | |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | M | 0.00 | 5,734 | 0 | 0 | |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | A | 0.00 | 4,356 | 0 | 4,356 | |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | A | 22.30 | 8,855 | 197,467 | 8,855 | |
Jun 22 2018 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Buy | M | 0.00 | 5,734 | 0 | 9,734 | 4 K to 9.7 K (+143.35 %) |
Nov 07 2017 | DMTX | Dimension Therapeu ... | GEMAYEL GEORGES | Director | Option Exercise | D | 1.15 | 17,000 | 19,550 | 0 | |
Nov 07 2017 | DMTX | Dimension Therapeu ... | GEMAYEL GEORGES | Director | Option Exercise | D | 7.08 | 32,069 | 227,049 | 0 | |
Nov 07 2017 | DMTX | Dimension Therapeu ... | GEMAYEL GEORGES | Director | Option Exercise | D | 4.85 | 44,474 | 215,699 | 0 | |
Jun 22 2017 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | A | 0.00 | 5,734 | 0 | 5,734 | |
Jun 22 2017 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | A | 17.20 | 11,207 | 192,760 | 11,207 | |
Jun 15 2017 | SUPN | SUPERNUS PHARMACEU ... | GEMAYEL GEORGES | Director | Option Exercise | A | 38.60 | 6,036 | 232,990 | 6,036 | |
Jun 15 2017 | SUPN | SUPERNUS PHARMACEU ... | GEMAYEL GEORGES | Director | Option Exercise | A | 38.60 | 6,036 | 232,990 | 6,036 | |
May 26 2017 | DMTX | Dimension Therapeu ... | GEMAYEL GEORGES | Director | Option Exercise | A | 1.15 | 17,000 | 19,550 | 17,000 | |
Feb 27 2017 | SUPN | SUPERNUS PHARMACEU ... | GEMAYEL GEORGES | Director | Option Exercise | A | 25.30 | 7,905 | 199,997 | 7,905 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Option Exercise | D | 5.22 | 7,915 | 41,316 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Sell | U | 9.00 | 2,092 | 18,828 | 8,330 | 10.4 K to 8.3 K (-20.07 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Grant | A | 0.00 | 8,330 | 0 | 10,422 | 2.1 K to 10.4 K (+398.18 %) |
May 23 2016 | DMTX | Dimension Therapeu ... | GEMAYEL GEORGES | Director | Option Exercise | A | 7.08 | 32,069 | 227,049 | 32,069 | |
Mar 03 2016 | SUPN | SUPERNUS PHARMACEU ... | GEMAYEL GEORGES | Director | Option Exercise | A | 12.98 | 15,000 | 194,700 | 15,000 | |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Option Exercise | A | 5.22 | 7,915 | 41,316 | 7,915 | |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Grant | A | 0.00 | 2,092 | 0 | 2,092 | 0 to 2.1 K |
Jan 05 2016 | MNTA | MOMENTA PHARMACEUT ... | GEMAYEL GEORGES | Director | Option Exercise | A | 14.84 | 30,000 | 445,200 | 30,000 | |
Mar 24 2015 | SUPN | SUPERNUS PHARMACEU ... | GEMAYEL GEORGES | Director | Option Exercise | A | 11.46 | 35,000 | 401,100 | 35,000 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | GEMAYEL GEORGES | Director | Option Exercise | D | 0.00 | 5,624 | 0 | 0 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | GEMAYEL GEORGES | Director | Option Exercise | D | 0.00 | 3,816 | 0 | 0 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | GEMAYEL GEORGES | Director | Option Exercise | D | 6.95 | 56,500 | 392,675 | 0 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | GEMAYEL GEORGES | Director | Sell | U | 46.00 | 9,000 | 414,000 | 0 | 9 K to 0 (-100.00 %) |
Jun 01 2004 | GENZ | GENZYME CORP | GEMAYEL GEORGES | Executive Vice Pres ... | Option Exercise | A | 43.90 | 69,615 | 3,056,099 | 69,615 | |
Jun 01 2004 | GENZ | GENZYME CORP | GEMAYEL GEORGES | Executive Vice Pres ... | Option Exercise | A | 43.90 | 11,385 | 499,802 | 11,385 |
Page: 1